Skip to content
Holistic Vive

Holistic Vive

Health is the key to success and happiness

Primary Menu Holistic Vive

Holistic Vive

  • Blood Clotting Healthcare
  • Kidney Healthcare
  • Liver Healthcare
  • Liver Cancer Healthcare
  • Brain Healthcare and Neurology
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • COVID

COVID

Ulster University ‘research breakthrough’ in early diagnosis of chronic kidney disease and Covid
  • Kidney Healthcare

Ulster University ‘research breakthrough’ in early diagnosis of chronic kidney disease and Covid

admin December 4, 2024 0

This pioneering research focuses on identifying specific protein markers in senescent cells—aged cells that stop dividing but don’t die—offering new...

Read MoreRead more about Ulster University ‘research breakthrough’ in early diagnosis of chronic kidney disease and Covid
Covishield: AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here’s what we know
  • Blood Clotting Healthcare

Covishield: AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here’s what we know

admin July 8, 2024 0

UK pharmaceutical giant AstraZeneca has admitted that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis...

Read MoreRead more about Covishield: AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here’s what we know
liver test developed by VCU researcher may serve as a new tool in battling COVID
  • Liver Healthcare

liver test developed by VCU researcher may serve as a new tool in battling COVID

admin January 4, 2024 0

By A.J. Hostetler A simple, widely used test developed by a Virginia Commonwealth University researcher to predict advanced liver disease...

Read MoreRead more about liver test developed by VCU researcher may serve as a new tool in battling COVID

Recent Posts

  • Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • AI in Liver Care Needs Vigilance and Tailoring to Population
  • Kidney Dialysis Equipment Market, In-Depth Analysis
  • KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Archives

Categories

  • Blood Clotting Healthcare
  • Brain Healthcare and Neurology
  • Kidney Healthcare
  • Liver Cancer Healthcare
  • Liver Healthcare

Visit Us

Financial Pinnacle Insights

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • Liver Cancer Healthcare

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0
AI in Liver Care Needs Vigilance and Tailoring to Population
  • Liver Healthcare

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0
Kidney Dialysis Equipment Market, In-Depth Analysis
  • Kidney Healthcare

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0
KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • Liver Cancer Healthcare

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
  • Liver Healthcare

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0
Copyright © All rights reserved. | CoverNews by AF themes.